Quantitative analysis of the relative mutagenicity of five chemical constituents of tobacco smoke in the mouse lymphoma assay

Mutagenesis

Volumn 31, Issue 3, 2016, Pages 287-296

  Guo, Xiaoqing ^a   Heflich, Robert H ^a   Dial, Stacey L ^a   Richter, Patricia A ^b,c   Moore, Martha M ^a,d   Mei, Nan ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b CENTER FOR TOBACCO PRODUCTS   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d ENVIRON INTERNATIONAL CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3,4 DIMETHYLIMIDAZO[4,5 F]QUINOLINE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 4 BIPHENYLAMINE; BENZO[A]PYRENE; CADMIUM; CIGARETTE SMOKE; TOBACCO SMOKE; 2-AMINO-3,4-DIMETHYLIMIDAZO(4,5-F)QUINOLINE; 4-(N-METHYL-N-NITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; 4-BIPHENYLAMINE; AMINOBIPHENYL DERIVATIVE; CADMIUM CHLORIDE; CARCINOGEN; DNA; MUTAGENIC AGENT; NITROSAMINE; QUINOLINE DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CHEMICAL COMPOSITION; CONTROLLED STUDY; CYTOTOXICITY; GENE MUTATION; GENOTOXICITY; LYMPHOMA CELL; LYMPHOMA CELL LINE; MALE; METABOLIC ACTIVATION; MOUSE; MUTAGENIC ACTIVITY; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; ANALYSIS; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DNA DAMAGE; DRUG EFFECTS; LYMPHOMA; METABOLISM; MUTAGEN TESTING; SMOKE; TOBACCO; TUMOR CELL LINE;

ACTIVATION, METABOLIC; AMINOBIPHENYL COMPOUNDS; ANIMALS; BENZO(A)PYRENE; CADMIUM CHLORIDE; CARCINOGENS; CELL LINE, TUMOR; DNA DAMAGE; DNA, NEOPLASM; LYMPHOMA; MICE; MUTAGENICITY TESTS; MUTAGENS; NITROSAMINES; QUINOLINES; RATS; SMOKE; TOBACCO;

EID: 84966659236     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/gev039     Document Type: Article

References (45)

1. CDC (2014) Health Effects of Cigarette Smoking. Smoking and Tobacco Use. http://www.cdc.gov/tobacco/data-statistics/fact-sheets/health-effects/effects-cig-smoking/index.htm#overview (accessed May 7, 2015).
2. WHO (2011) WHO Report on the Global Tobacco Epidemic. World Health Organization. http://whqlibdoc.who.int/publications/2009/9789241563918-eng-full.pdf (accessed May 7, 2015).
3. CDC (2014) Mechanisms of Cancer Induction by Tobacco Smoke. In U.S. Department of Health and Human Services (ed.), 2014 Surgeon General's Report: The Health Consequences of Smoking-50 Years of Progress. pp. 148-151.
4. IARC (2012) Tobacco smoking, a review of human carcinogens: personal habits and indoor combustions. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 100E, 43-212.
5. Hecht, S. S. (2003) Tobacco carcinogens, their biomarkers and tobaccoinduced cancer. Nat. Rev. Cancer, 3, 733-744.
6. EPA (2005) Guildelines for carcinogen risk assessment. U.S. Environmental Protection Agency. http://www2.epa.gov/sites/production/files/2013-09/documents/cancer-guidelines-final-3-25-05.pdf (accessed May 7, 2015).
7. DeMarini, D. M. (2004) Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat. Res., 567, 447-474.
8. DeMarini, D. M., Gudi, R., Szkudlinska, A., Rao, M., Recio, L., Kehl, M., Kirby, P. E., Polzin, G., Richter, P. A. (2008) Genotoxicity of 10 cigarette smoke condensates in four test systems: comparisons between assays and condensates. Mutat. Res., 650, 15-29.
9. Foy, J. W., Bombick, B. R., Bombick, D. W., Doolittle, D. J., Mosberg, A. T., Swauger, J. E. (2004) A comparison of in vitro toxicities of cigarette smoke condensate from Eclipse cigarettes and four commercially available ultra low-"tar" cigarettes. Food Chem. Toxicol., 42, 237-243.
10. Guo, X., Verkler, T. L., Chen, Y., Richter, P. A., Polzin, G. M., Moore, M. M., Mei, N. (2011) Mutagenicity of 11 cigarette smoke condensates in two versions of the mouse lymphoma assay. Mutagenesis, 26, 273-281.
11. Lou, J., Zhou, G., Chu, G., Jiang, J., Huang, F., Zheng, S., Lu, Y., Li, X., He, J. (2010) Studying the cyto-genotoxic effects of 12 cigarette smoke condensates on human lymphoblastoid cell line in vitro. Mutat. Res., 696, 48-54.
12. Roemer, E., Stabbert, R., Rustemeier, K., Veltel, D. J., Meisgen, T. J., Reininghaus, W., Carchman, R. A., Gaworski, C. L., Podraza, K. F. (2004) Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. Toxicology, 195, 31-52.
13. Schramke, H., Meisgen, T. J., Tewes, F. J., Gomm, W., Roemer, E. (2006) The mouse lymphoma thymidine kinase assay for the assessment and comparison of the mutagenic activity of cigarette mainstream smoke particulate phase. Toxicology, 227, 193-210.
14. Gollapudi, B. B., Johnson, G. E., Hernandez, L. G. et al. (2013) Quantitative approaches for assessing dose-response relationships in genetic toxicology studies. Environ. Mol. Mutagen., 54, 8-18.
15. Johnson, G. E., Soeteman-Hern?dez, L. G., Gollapudi, B. B. et al. (2014) Derivation of point of departure (PoD) estimates in genetic toxicology studies and their potential applications in risk assessment. Environ. Mol. Mutagen., 55, 609-623.
16. MacGregor, J. T., Fr?schl, R., White, P. A. et al. (2015) IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of pointof-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk. Mutat Res, 783, 66-78.
17. MacGregor, J. T., Fr?schl, R., White, P. A, et al. (2015) IWGT report on quantitative approaches to genotoxicity risk assessment I. Methods and metrics for defining exposure-response relationships and points of departure (PoDs). Mutat Res, 783, 55-65.
18. Cao, X., Mittelstaedt, R. A., Pearce, M. G., Allen, B. C., Soeteman-Hern?dez, L. G., Johnson, G. E., Bigger, C. A., Heflich, R. H. (2014) Quantitative dose-response analysis of ethyl methanesulfonate genotoxicity in adult gpt-delta transgenic mice. Environ. Mol. Mutagen., 55, 385-399.
19. Hern?dez, L. G., Van Benthem, J., Johnson, G. E. (2013) A modeof-action approach for the identification of genotoxic carcinogens. PLoS One, 8, e64532.
20. Recio, L., Shepard, K. G., Hern?dez, L. G., Kedderis, G. L. (2012) Dose-response assessment of naphthalene-induced genotoxicity and glutathione detoxication in human TK6 lymphoblasts. Toxicol. Sci., 126, 405-412.
21. Tang, L., Gu?ard, M., Zeller, A. (2014) Quantitative assessment of the dose-response of alkylating agents in DNA repair proficient and deficient ames tester strains. Environ. Mol. Mutagen., 55, 15-23.
22. EFSA (2009) Guidance of the Scientific Committee on a request from EFSA on the use of the benchmark dose approach in risk assessment. EFSA J., 1150, 1-72.
23. Burgoon, L. D., Zacharewski, T. R. (2008) Automated quantitative dose-response modeling and point of departure determination for large toxicogenomic and high-throughput screening data sets. Toxicol. Sci., 104, 412-418.
24. Davis, J. A., Gift, J. S., Zhao, Q. J. (2011) Introduction to benchmark dose methods and U.S. EPA's benchmark dose software (BMDS) version 2.1.1. Toxicol. Appl. Pharmacol., 254, 181-191.
25. Smith, C. J., Livingston, S. D., Doolittle, D. J. (1997) An international literature survey of "IARC Group I carcinogens" reported in mainstream cigarette smoke. Food Chem. Toxicol., 35, 1107-1130.
26. Smith, C. J., Perfetti, T. A., Rumple, M. A., Rodgman, A., Doolittle, D. J. (2001) "IARC Group 2B carcinogens" reported in cigarette mainstream smoke. Food Chem. Toxicol., 39, 183-205.
27. National Toxicology Program (2011) NTP 12th Report on Carcinogens. Rep Carcinog, 12, 111-499.
28. IARC (2012) Second-hand tobacco smoke, a review of human carcinogens: personal habits and indoor combustions. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 100E, 213-264.
29. Ding, Y. S., Ashley, D. L., Watson, C. H. (2007) Determination of 10 carcinogenic polycyclic aromatic hydrocarbons in mainstream cigarette smoke. J. Agric. Food Chem., 55, 5966-5973.
30. IARC (2004) Involuntary smoking, tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 83, 1189-1414.
31. National Toxicology Program (2002) Selected Heterocyclic Amines: PhIP, MeIQ, and MeIQx. Final Report on Carcinogens Background Document. http://ntp.niehs.nih.gov/ntp/newhomeroc/roc11/hcaspub.pdf (accessed May 7, 2015).
32. IARC (2012) Benzo[a]pyrene, a review of human carcinogens: chemical agents and related occupations. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 100F, 111-144.
33. Hammond, D., O'Connor, R. J. (2008) Constituents in tobacco and smoke emissions from Canadian cigarettes. Tob. Control, 17(Suppl 1), i24-i31.
34. Applegate, M. L., Moore, M. M., Broder, C. B., Burrell, A., Juhn, G., Kasweck, K. L., Lin, P. F., Wadhams, A., Hozier, J. C. (1990) Molecular dissection of mutations at the heterozygous thymidine kinase locus in mouse lymphoma cells. Proc. Natl Acad. Sci. U. S. A., 87, 51-55.
35. Wang, J., Sawyer, J. R., Chen, L., Chen, T., Honma, M., Mei, N., Moore, M. M. (2009) The mouse lymphoma assay detects recombination, deletion, and aneuploidy. Toxicol. Sci., 109, 96-105.
36. Mei, N., Xia, Q., Chen, L., Moore, M. M., Chen, T., Fu, P. P. (2006) Photomutagenicity of anhydroretinol and 5,6-epoxyretinyl palmitate in mouse lymphoma cells. Chem. Res. Toxicol., 19, 1435-1440.
37. Mei, N., Guo, X., Moore, M.M. (2014) Methods for using the mouse lymphoma assay to screen for chemical mutagenicity and photo-mutagenicity. In Caldwell, G.W., Yan, Z. (eds.), Optimization in Drug Discovery: In-vitro Methods. Humana Press, New York, pp. 561-592.
38. Mei, N., Zhang, Y., Chen, Y. et al. (2012) Silver nanoparticle-induced mutations and oxidative stress in mouse lymphoma cells. Environ. Mol. Mutagen., 53, 409-419.
39. Moore, M. M., Honma, M., Clements, J. et al. (2006) Mouse lymphoma thymidine kinase gene mutation assay: follow-up meeting of the International Workshop on Genotoxicity Testing-Aberdeen, Scotland, 2003-Assay acceptance criteria, positive controls, and data evaluation. Environ. Mol. Mutagen., 47, 1-5.
40. Arlt, V. M., Stiborov? M., Henderson, C. J. et al. (2008) Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice. Carcinogenesis, 29, 656-665.
41. Schrader, E., Hirsch-Ernst, K. I., Scholz, E., Kahl, G. F., Foth, H. (2000) Metabolism of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in primary cultures of rat alveolar type II cells. Drug Metab. Dispos., 28, 180-185.
42. Luch, A. (2005) Nature and nurture-lessons from chemical carcinogenesis. Nat. Rev. Cancer, 5, 113-125.
43. Klaassen, C. D., Liu, J., Diwan, B. A. (2009) Metallothionein protection of cadmium toxicity. Toxicol. Appl. Pharmacol., 238, 215-220.
44. Slob, W., Setzer, R. W. (2014) Shape and steepness of toxicological dose-response relationships of continuous endpoints. Crit. Rev. Toxicol., 44, 270-297.
45. Travis, K. Z., Pate, I., Welsh, Z. K. (2005) The role of the benchmark dose in a regulatory context. Regul. Toxicol. Pharmacol., 43, 280-291.